Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses
- Conditions
- Refractive Errors
- Registration Number
- NCT05886894
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.
- Detailed Description
This is a non-interventional/observational study designed as a retrospective chart review. Study sites will identify charts within their existing databases in a fair and consistent manner, e.g., reviewing all eligible charts in reverse chronological order by year of baseline visit. The baseline visit will be defined as the first office visit where an eye care practitioner provided an in-person office biomicroscopy exam to the patient, before or during which a contact lens prescription for the study or comparator contact lenses was released. Subjects/charts meeting the eligibility criteria will be enrolled in the study.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 265
- Best Corrected Visual Acuity (BCVA) of 20/25 Snellen or better in each eye at baseline;
- Must have worn or be wearing Air Optix plus Hydraglyde Multifocal or Biofinity Multifocal for at least 1 year in a daily wear modality, or 3 years in an extended wear modality;
- Other protocol-defined inclusion criteria may apply.
- Any recurrent history or active anterior segment infection, inflammation or abnormality contraindicating regular contact lens wear at baseline;
- Use of systemic or ocular medications contraindicating regular contact lens wear at baseline and/or during the period of the retrospective chart collection;
- Slit lamp findings, including signs of pathological dry eye, that would contraindicate regular contact lens wear;
- Participation of the patient in a contact lens or contact lens care product trial during the period of the retrospective chart collection;
- Other protocol-defined exclusion criteria may apply.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Near visual acuity at 1 year - Daily Wear Year 1 The subject's chart will be reviewed for near visual acuity at Year 1, defined as the visit which occurred 1 year (-2/+4 months) since baseline, during which period the subject was wearing the protocol required contact lenses and a contact lens examination was performed. This outcome measure is prespecified for the daily wear arms (Air Optix plus HydraGlyde Multifocal Daily Wear and Biofinity Multifocal Daily Wear).
Distance visual acuity at 1 year - Daily Wear Year 1 The subject's chart will be reviewed for distance visual acuity at Year 1, defined as the visit which occurred 1 year (-2/+4 months) since baseline, during which period the subject was wearing the protocol required contact lenses and a contact lens examination was performed. This outcome measure is prespecified for the daily wear arms (Air Optix plus HydraGlyde Multifocal Daily Wear and Biofinity Multifocal Daily Wear).
Incidence of corneal infiltrative events - Daily Wear Up to Year 1 The subject's chart will be reviewed for incidences of corneal infiltrative events occurring after the baseline exam. This outcome measure is prespecified for the daily wear arms (Air Optix plus HydraGlyde Multifocal Daily Wear and Biofinity Multifocal Daily Wear).
Incidence of corneal infiltrative events - Extended Wear Up to Year 3 The subject's chart will be reviewed for incidences of corneal infiltrative events occurring after the baseline exam. This outcome measure is prespecified for the extended wear arms (Air Optix plus HydraGlyde Multifocal Extended Wear and Biofinity Multifocal Extended Wear).
Distance visual acuity at 3 years - Extended Wear Year 3 The subject's chart will be reviewed for distance visual acuity at Year 3, defined as the visit which occurred 3 years (-2/+8 months) since baseline, during which period the subject was wearing the protocol required contact lenses and a contact lens examination was performed. This outcome measure is prespecified for the extended wear arms (Air Optix plus HydraGlyde Multifocal Extended Wear and Biofinity Multifocal Extended Wear).
Near visual acuity at 3 years - Extended Wear Year 3 The subject's chart will be reviewed for near visual acuity at Year 3, defined as the visit which occurred 3 years (-2/+8 months) since baseline, during which period the subject was wearing the protocol required contact lenses and a contact lens examination was performed. This outcome measure is prespecified for the extended wear arms (Air Optix plus HydraGlyde Multifocal Extended Wear and Biofinity Multifocal Extended Wear).
Incidence of microbial keratitis - Daily Wear Up to Year 1 The subject's chart will be reviewed for incidences of microbial keratitis occurring after the baseline exam. This outcome measure is prespecified for the daily wear arms (Air Optix plus HydraGlyde Multifocal Daily Wear and Biofinity Multifocal Daily Wear).
Incidence of microbial keratitis - Extended Wear Up to Year 3 The subject's chart will be reviewed for incidences of microbial keratitis occurring after the baseline exam. This outcome measure is prespecified for the extended wear arms (Air Optix plus HydraGlyde Multifocal Extended Wear and Biofinity Multifocal Extended Wear).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Complete Family Vision Care
🇺🇸San Diego, California, United States
Pearle Vision
🇺🇸Jacksonville, Florida, United States
Jackson Health Community Center
🇺🇸Miami, Florida, United States
Vision Health Institute
🇺🇸Orlando, Florida, United States
Complete Eye Care of Medina
🇺🇸Medina, Minnesota, United States
Koetting Associates
🇺🇸Saint Louis, Missouri, United States
Sacco Eye Group
🇺🇸Vestal, New York, United States
Smith Bowman Ophthalmology
🇺🇸Salt Lake City, Utah, United States
Complete Family Vision Care🇺🇸San Diego, California, United States